191 related articles for article (PubMed ID: 31026245)
41. Inhibition of left ventricular remodelling preserves chamber systolic function in pressure-overloaded mice.
Marano G; Palazzesi S; Vergari A; Catalano L; Gaudi S; Testa C; Canese R; Carpinelli G; Podo F; Ferrari AU
Pflugers Arch; 2003 Jul; 446(4):429-36. PubMed ID: 12715181
[TBL] [Abstract][Full Text] [Related]
42. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
43. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
Litwin SE; Katz SE; Weinberg EO; Lorell BH; Aurigemma GP; Douglas PS
Circulation; 1995 May; 91(10):2642-54. PubMed ID: 7743628
[TBL] [Abstract][Full Text] [Related]
44. Physiological and pathological left ventricular hypertrophy of comparable degree is associated with characteristic differences of in vivo hemodynamics.
Oláh A; Németh BT; Mátyás C; Hidi L; Lux Á; Ruppert M; Kellermayer D; Sayour AA; Szabó L; Török M; Meltzer A; Gellér L; Merkely B; Radovits T
Am J Physiol Heart Circ Physiol; 2016 Mar; 310(5):H587-97. PubMed ID: 26718969
[TBL] [Abstract][Full Text] [Related]
45. The Association Between Myocardial Fibrosis and Depressed Capillary Density in Rat Model of Left Ventricular Hypertrophy.
Xiao Y; Liu Y; Liu J; Kang YJ
Cardiovasc Toxicol; 2018 Aug; 18(4):304-311. PubMed ID: 29204738
[TBL] [Abstract][Full Text] [Related]
46. Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload.
Shinde AV; Su Y; Palanski BA; Fujikura K; Garcia MJ; Frangogiannis NG
J Mol Cell Cardiol; 2018 Apr; 117():36-48. PubMed ID: 29481819
[TBL] [Abstract][Full Text] [Related]
47. Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression.
Byrne NJ; Levasseur J; Sung MM; Masson G; Boisvenue J; Young ME; Dyck JR
Cardiovasc Res; 2016 May; 110(2):249-57. PubMed ID: 26968698
[TBL] [Abstract][Full Text] [Related]
48. Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure.
Hutchinson KR; Guggilam A; Cismowski MJ; Galantowicz ML; West TA; Stewart JA; Zhang X; Lord KC; Lucchesi PA
J Appl Physiol (1985); 2011 Dec; 111(6):1778-88. PubMed ID: 21885799
[TBL] [Abstract][Full Text] [Related]
49. Load-Dependent Changes in Left Ventricular Structure and Function in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure.
Weinheimer CJ; Kovacs A; Evans S; Matkovich SJ; Barger PM; Mann DL
Circ Heart Fail; 2018 May; 11(5):e004351. PubMed ID: 29716898
[TBL] [Abstract][Full Text] [Related]
50. Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats.
Cingolani OH; Yang XP; Liu YH; Villanueva M; Rhaleb NE; Carretero OA
Hypertension; 2004 May; 43(5):1067-73. PubMed ID: 15023934
[TBL] [Abstract][Full Text] [Related]
51. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
[TBL] [Abstract][Full Text] [Related]
52. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
53. Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation?
Kuwahara F; Kai H; Tokuda K; Takeya M; Takeshita A; Egashira K; Imaizumi T
Hypertension; 2004 Apr; 43(4):739-45. PubMed ID: 14967845
[TBL] [Abstract][Full Text] [Related]
54. Transition from compensated hypertrophy to intrinsic myocardial dysfunction during development of left ventricular pressure-overload hypertrophy in conscious sheep. Systolic dysfunction precedes diastolic dysfunction.
Aoyagi T; Fujii AM; Flanagan MF; Arnold LW; Brathwaite KW; Colan SD; Mirsky I
Circulation; 1993 Nov; 88(5 Pt 1):2415-25. PubMed ID: 8222134
[TBL] [Abstract][Full Text] [Related]
55. Regression of left ventricular hypertrophy in experimental renovascular hypertension: diastolic dysfunction depends more on myocardial collagen than it does on myocardial mass.
Dussaillant GR; Gonzalez H; Cespedes C; Jalil JE
J Hypertens; 1996 Sep; 14(9):1117-23. PubMed ID: 8986913
[TBL] [Abstract][Full Text] [Related]
56. Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy.
Rothermund L; Kreutz R; Kossmehl P; Fredersdorf S; Shakibaei M; Schulze-Tanzil G; Paul M; Grimm D
Am J Hypertens; 2002 Jul; 15(7 Pt 1):644-52. PubMed ID: 12118914
[TBL] [Abstract][Full Text] [Related]
57. Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats.
Wang LJ; He JG; Ma H; Cai YM; Liao XX; Zeng WT; Liu J; Wang LC
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):481-7. PubMed ID: 15897115
[TBL] [Abstract][Full Text] [Related]
58. Coronary dilator reserve and morphological changes after relief of pressure-overload in rats.
Ito N; Isoyama S; Takahashi T; Takishima T
J Mol Cell Cardiol; 1993 Jan; 25(1):3-14. PubMed ID: 8441179
[TBL] [Abstract][Full Text] [Related]
59. Chronic L-arginine treatment increases cardiac cyclic guanosine 5'-monophosphate in rats with aortic stenosis: effects on left ventricular mass and beta-adrenergic contractile reserve.
Bartunek J; Dempsey S; Weinberg EO; Ito N; Tajima M; Rohrbach S; Lorell BH
J Am Coll Cardiol; 1998 Aug; 32(2):528-35. PubMed ID: 9708487
[TBL] [Abstract][Full Text] [Related]
60. Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis.
Podesser BK; Kreibich M; Dzilic E; Santer D; Förster L; Trojanek S; Abraham D; Krššák M; Klein KU; Tretter EV; Kaun C; Wojta J; Kapeller B; Gonçalves IF; Trescher K; Kiss A
J Hypertens; 2018 Apr; 36(4):847-856. PubMed ID: 29283973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
